Dilly S - Search Results

1

Homology modeling of MT1 and MT2 receptors.

Farce A, Chugunov AO, Logé C, Sabaouni A, Yous S, Dilly S, Renault N, Vergoten G, Efremov RG, Lesieur D, Chavatte P. Farce A, et al. Among authors: dilly s. Eur J Med Chem. 2008 Sep;43(9):1926-44. doi: 10.1016/j.ejmech.2007.12.001. Epub 2007 Dec 14. Eur J Med Chem. 2008. PMID: 18255198

2

Homology modelling of the serotoninergic 5-HT2c receptor.

Farce A, Dilly S, Yous S, Berthelot P, Chavatte P. Farce A, et al. Among authors: dilly s. J Enzyme Inhib Med Chem. 2006 Jun;21(3):285-92. doi: 10.1080/14756360600700608. J Enzyme Inhib Med Chem. 2006. PMID: 16918076

3

Identification of a pharmacophore of SKCa channel blockers.

Dilly S, Graulich A, Farce A, Seutin V, Liegeois JF, Chavatte P. Dilly S, et al. J Enzyme Inhib Med Chem. 2005 Dec;20(6):517-23. doi: 10.1080/14756360500210989. J Enzyme Inhib Med Chem. 2005. PMID: 16408787

4

Quantitative structure-activity relationships studies of antioxidant hexahydropyridoindoles and flavonoid derivatives.

Durand AC, Farce A, Carato P, Dilly S, Yous S, Berthelot P, Chavatte P. Durand AC, et al. Among authors: dilly s. J Enzyme Inhib Med Chem. 2007 Oct;22(5):556-62. doi: 10.1080/14756360701425238. J Enzyme Inhib Med Chem. 2007. PMID: 18035823

5

Molecular modelling of phthalates - PPARs interactions.

Kambia N, Renault N, Dilly S, Farce A, Dine T, Gressier B, Luyckx M, Brunet C, Chavatte P. Kambia N, et al. Among authors: dilly s. J Enzyme Inhib Med Chem. 2008 Oct;23(5):611-6. doi: 10.1080/14756360802205059. J Enzyme Inhib Med Chem. 2008. PMID: 18821250

6

Antioxydant activity of β-carboline derivatives in the LDL oxidation model.

Hadjaz F, Besret S, Martin-Nizard F, Yous S, Dilly S, Lebegue N, Chavatte P, Duriez P, Berthelot P, Carato P. Hadjaz F, et al. Among authors: dilly s. Eur J Med Chem. 2011 Jun;46(6):2575-85. doi: 10.1016/j.ejmech.2011.03.048. Epub 2011 Mar 30. Eur J Med Chem. 2011. PMID: 21497423

7

Synthesis and radioligand binding studies of bis-isoquinolinium derivatives as small conductance Ca(2+)-activated K(+) channel blockers.

Graulich A, Dilly S, Farce A, Scuvée-Moreau J, Waroux O, Lamy C, Chavatte P, Seutin V, Liégeois JF. Graulich A, et al. Among authors: dilly s. J Med Chem. 2007 Oct 18;50(21):5070-5. doi: 10.1021/jm070412j. Epub 2007 Sep 15. J Med Chem. 2007. PMID: 17867663

8

Bis-tetrahydroisoquinoline derivatives: AG525E1, a new step in the search for non-quaternary non-peptidic small conductance Ca(2+)-activated K(+) channel blockers.

Graulich A, Lamy C, Alleva L, Dilly S, Chavatte P, Wouters J, Seutin V, Liégeois JF. Graulich A, et al. Among authors: dilly s. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3440-5. doi: 10.1016/j.bmcl.2008.03.069. Epub 2008 Mar 29. Bioorg Med Chem Lett. 2008. PMID: 18436444

9

Modulation of the 6-position of benzopyran derivatives and inhibitory effects on the insulin releasing process.

Florence X, Dilly S, de Tullio P, Pirotte B, Lebrun P. Florence X, et al. Among authors: dilly s. Bioorg Med Chem. 2011 Jul 1;19(13):3919-28. doi: 10.1016/j.bmc.2011.05.040. Epub 2011 May 24. Bioorg Med Chem. 2011. PMID: 21664825

10

Synthesis and radioligand binding studies of bis-(8-isopropyl-isoquinolinium) derivatives as ligands for apamin-sensitive sites on cloned SK2 and SK3 channels.

Badarau E, Dilly S, Dufour F, Poncin S, Seutin V, Liégeois JF. Badarau E, et al. Among authors: dilly s. Bioorg Med Chem Lett. 2011 Nov 15;21(22):6756-9. doi: 10.1016/j.bmcl.2011.09.043. Epub 2011 Sep 16. Bioorg Med Chem Lett. 2011. PMID: 21978678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page